Stem Cell Aggregate Formation for Neural Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inducing differentiation of pluripotent stem cells, particularly into cerebral cortical tissue and hypothalamic neurons, face low efficiency and morphological disarray, with conventional serum-free media inhibiting specific tissue types due to growth factors and insulin.
Innovation Solution
A method involving forming homogenous aggregates of stem cells in serum-free media without centrifugation, followed by suspension culture, and using specific inhibitors like Akt and PI3K inhibitors to avoid growth factor and insulin inhibition, allowing for efficient differentiation into cerebral cortical and hypothalamic neurons.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional SFEB method is used for stem cell differentiation, then nerve cells can be induced, but the induction efficiency is low and tissue morphology is disarrayed
Solution Approach 1:
The patent applies preliminary action by pre-forming homogenous aggregates of stem cells before differentiation induction. The method involves enclosing a specific number of stem cells in microwell plates to form aggregates, then inducing differentiation. This preliminary aggregation step ensures uniform cell distribution and epithelization before differentiation, leading to improved induction efficiency and organized tissue morphology compared to conventional SFEB method.
2Reliability
If serum-free medium containing growth factors and insulin is used, then cell survival is maintained, but differentiation into specific tissue types is inhibited
Solution Approach 1:
The patent applies the taking out principle by removing growth factors and insulin from the serum-free medium during the differentiation induction phase. The method uses a two-stage approach: first culturing stem cells in serum-free medium to maintain survival, then switching to medium without growth factors and insulin to enable efficient differentiation into specific tissue types such as cerebral cortical and hypothalamic neurons.
Solution Approach 2:
The patent applies dynamics by dynamically changing the culture conditions throughout the differentiation process. The method transitions from serum-free medium with growth factors for initial cell maintenance to serum-free medium without growth factors and insulin for differentiation induction, and finally to medium with specific inhibitors for enhanced tissue type specification. This dynamic adjustment of medium composition optimizes both cell survival and differentiation efficiency at different stages.
3Speed
If centrifugation is used in aggregate formation, then cell aggregation is accelerated, but cell damage and heterogeneity increase
Solution Approach 1:
The patent applies mechanics substitution by replacing the mechanical centrifugation process with a chemical/biochemical approach. Instead of using centrifugal force to accelerate aggregation, the method uses microwell plates with specific surface properties and optimized medium composition to promote spontaneous cell aggregation. This substitution eliminates mechanical stress and cell damage while achieving homogeneous aggregates through controlled biochemical interactions.
Data Source
Figure 1A~1O
Figure 2A~2F
Figure 3-1A~3-1H
AI summary
The present invention enables efficient suspension culture of stem cells in a serum-free medium by comprising a step for quickly forming a homogenous aggregate of stem cells, and provides a method of selectively inducing the differentiation of nerves from a stem cell, a method of forming a cerebral cortical nerve network in vitro, and a method of producing a steric structure of a brain tissue in vitro, as well as a method of producing hypothalamic neuron progenitor cells, comprising culturing pluripotent stem cells as a suspended aggregate in a serum-free medium that substantially does not contain a Nodal signal promoter, a Wnt signal promoter, an FGF signal promoter, a BMP signal promoter, retinoic acid and an insulin, and isolating hypothalamic neuron progenitor cells from the culture.